Cannabis can help relieve low chronic back pain, and find the main experience

People with poor bad appearance may have a close cause of jumping for joy – of course. A large -scale clinical, random, double -blind, and controlled clinical trial showed that the specifically designed hemp extract can significantly reduce people’s back pain.

German pharmaceutical company Tapes The developer developed, VER-01 called a symbol, and sponsoring the third stage experience. The study researchers found that people who took Ver-01 suffer from a greater pain decrease compared to the people in the placebo. The company has already submitted with the organizational approval of drugs in Europe and plans to secure the approval of the US Food and Drug Administration.

Strong evidence

The experiment, which was conducted in several different stages, included more than 800 people who were diagnosed with low -back pain. In the first stage, they were randomly chosen from almost half of the participants to receive Ver-01 (taken orally daily), while the other half received a control material. Then the researchers followed the participants for 12 weeks.

By the end of the 12th week, the VER-01 group showed a statistically improvement in pain on the imaginary drug group.

On a scale of 11 commonly used pain evaluation, people who are taking VER-01 saw a decrease of 1.9 points on average, for example, compared to an average of 1.4 points in the fake group. People who continued to take the medicine after the first stage suffered from reduced pain over time as well. Those on VER-01 also reported a greater improvement in sleep quality and physical performance, while the drug seemed to have been safely tolerated, with no signs of dependence or withdrawal.

“In conclusion, this study provides in stage 3 strong evidence that supports VER-01 safety in the treatment of (chronic lower back pain)”, the authors wrote in their paper, Published Monday in nature medicine.

External experts seem excited about the potential of the drug as well.

“This is an excellent study. We have long argued that studies on cannabis or cannabis materials need to provide a high level of evidence: this is,” Jan Vollert, lecturer in Extreme University in the United Kingdom, He said Scientific Information Center. “It is only one experience, and we will need more studies to confirm the results, but this is a good indication that the compound can help patients.”

Ver-01 future

Many studies Proposal The hemp, the initial compounds in the hemp, can help treat pain. Countries in Europe and Asia also have Licensed Specific installations of cannabis to treat nerve pain. yet Other research has failed To show a consistent effect of hemp.

Some of these mixed evidence may be due to the fact that hashish comes in many different strains, each of which has a variety or a different percentage of these compounds. The dimensions and their researchers argue that his extract has the correct mixture of hemp and other ingredients to reliably provide pain. It is worth noting that the extract contains only 5 % THC. Although THC is the component responsible for the “height” of hashish, the level in VER-01 is lower than it is usually found in the entertainment products or breeds available today (often arrives 15 % or higher).

Reducing the pain documented in this last study is relatively modest. But gave The lack of other ineffective options For back pain, VER-01 can definitely become a widely used alternative treatment, and one without harmful addiction. It is able to do so About 40 % From adults in the United States suffer from back pain in the past three months, while More than 10 % Of Americans, they may currently suffer from chronic back pain.

After the first release of the third stage data earlier this year, Vertanical has already made Present For VER-01 approval in Europe; He is planning to approve approval in the UK as well. The company also holds talks with the FDA to design a study, if it succeeds, it can convince the American organizer to grant approval.